AVIDA BIOTECH

avida-biotech-logo

Developing a broad-spectrum antiviral to prevent neglected infectious diseases - Dengue, Chikungunya and Zika

#SimilarOrganizations #People #Website #More

AVIDA BIOTECH

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2016-01-01

Address:
Barcelona, Catalonia, Spain

Country:
Spain

Website Url:
http://www.avida-biotech.com

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Font Awesome Global Site Tag


Similar Organizations

henry-ford-health-system-logo

Henry Ford Health System

Henry Ford Health System (HFHS) is one of the nationโ€™s leading comprehensive, integrated health systems.

siduma-therapeutics-logo

Siduma Therapeutics

Siduma Therapeutics builds a disruptive new class of medicines for better healthcare.

zemu-venture-capital-logo

ZEMU Venture Capital

Backing global entrepreneurs through our various funding programs.

Current Employees Featured

jesรบs-purroy_image

Jesรบs Purroy
Jesรบs Purroy CEO and Founder @ Avida Biotech
CEO and Founder
2016-10-01

Founder


jesรบs-purroy_image

Jesรบs Purroy

Official Site Inspections

http://www.avida-biotech.com

  • Host name: vxhcr-40.srv.cat
  • IP address: 185.66.41.202
  • Location: Spain
  • Latitude: 40.4172
  • Longitude: -3.684
  • Timezone: Europe/Madrid

Loading ...

More informations about "Avida Biotech"

About Us - Àvida Biotech

Àvida Biotech. Navigation Menu. Navigation Menu Homepage; About Us; Products; Contact; About Us. We are a diverse team that includes collaborators and advisors from around the โ€ฆSee details»

Avida Biotech - Crunchbase Company Profile & Funding

9,994 Number of Organizations โ€ข $56.6B Total Funding Amount โ€ข 9,806 Number of Investors. Track . Private Barcelona Companies (Top 10K) ... Avida Biotech is located in Barcelona, โ€ฆSee details»

Àvida Biotech - LinkedIn

Àvida Biotech | 215 followers on LinkedIn. Developing affordable vaccines for neglected and emerging infectious diseases. | We are developing broad-spectrum antiviral products to โ€ฆSee details»

Products - Àvida Biotech

Àvida Biotech. Navigation Menu. Navigation Menu Homepage; About Us; Products; Contact; Our products. We develop innovative products to address urgent global health issues. Vaccines โ€ฆSee details»

Àvida Biotech - Company profile | ensun

Who is Àvida Biotech? We are a diverse team that includes collaborators and advisors from around the world. Our mission is to reduce the global impact of infectious diseases through the โ€ฆSee details»

Àvida Biotech, S.L. | Barcelona, Spain Startup

Website avida-biotech.com; Company Summary We are developing a broad-spectrum antiviral to prevent and treat infectious diseases, with a focus on diseases such as Dengue, which have a โ€ฆSee details»

UB CIGBS partners with Àvida Biotech - University at Buffalo

Nov 4, 2020 Morse will also join the Àvida Biotech scientific advisory board as a voluntary member. Purroy will join CIGBS as a visiting professor. โ€œThis is a great opportunity for the โ€ฆSee details»

Àvida Biotech, S.L. - VentureRadar

"Developing a broad-spectrum antiviral to prevent neglected infectious diseases. Our priority targets are Dengue, Chikungunya and ZikaWe have validated our antiviral with several viruses โ€ฆSee details»

Àvida Biotech, S.L. - VentureRadar

Developing a broad-spectrum antiviral to prevent neglected infectious diseases. Our priority targets are Dengue, Chikungunya and ZikaWe have... ... Find out more ...See details»

Jesús Purroy - CEO and Founder @ Avida Biotech - Crunchbase

Jesús Purroy has 4 current jobs including CEO and Founder at Avida Biotech, Member at Catalan Council of Scientific Communication, and Project Director - Life sciences at I will find the โ€ฆSee details»

Contact - Àvida Biotech

We are always interested in hearing from people who share our goals. Feel free to drop us a line to discuss collaborations, funding opportunities and joining the team.See details»

A New Broad-Spectrum Antiviral Against Neglected and

Jan 16, 2018 Jesús Purroy (Àvida-Biotech) Àvida-Biotech is developing products derived from a broad-spectrum antiviral called ABT001 , that has been validated in vitro with several viruses. โ€ฆSee details»

โ˜‘๏ธAvida Biotech โ€” Other from Spain โ€” Health sector

Avida Biotech โ€” Other from Spain, it`s involved in Health sectorSee details»

Avida Biotech - Contacts, Employees, Board Members

Organization. Avida Biotech . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Edit Contacts Section. We're working on getting contact data for โ€ฆSee details»

UB CIGBS partners with Àvida Biotech to advance vaccines for โ€ฆ

Nov 4, 2020 Toggle Navigation Menu. 12/18/23 About. 11/22/23 AcademicsSee details»

Avida Biomed Company Profile 2025: Valuation, Investors

When was Avida Biomed founded? Avida Biomed was founded in 2018. Where is Avida Biomed headquartered? Avida Biomed is headquartered in Fremont, CA. What is the size of Avida โ€ฆSee details»

Àvida Biotech, S.L. | VentureRadar

Website: http://www.avida-biotech.com/ Develops broad-spectrum antivirals targeting neglected infectious diseases, focusing on Dengue, Chikungunya, and Zika, with in ...See details»

Avida Biomed: early cancer detection with methylation

Jun 5, 2020 The founders of Avida Biomed were inventors of the Solexa flowcell. Stay tuned for an AACR presentation from the team showcasing performance data for Point-n-Seq and โ€ฆSee details»

Labviva Secures $25M to Accelerate Product Development and

3 days ago BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Labviva, the leading AI procurement platform for life sciences, today announced the close of its $25 million Series B, โ€ฆSee details»

Àvida Biotech, S.L. - VentureRadar

Similar Companies: Globavir USA Privately Held Globavir Biosciences is a San Francisco Bay Area based company committed to the development of therapeutics and diagnostics for the โ€ฆSee details»

linkstock.net © 2022. All rights reserved